UPH - UpHealth, Inc.
NYSE
->
Healthcare
->
Health Information Services
Delray Beach,
United States
Type: Equity
UPH price evolution
UPH
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $16.5 | $22.37 | $24.43 | $21.86 |
| Inventory | $0.02 | $0.13 | $0.16 | |
| Total current assets | $22 | $71.31 | $44.34 | $43.32 |
| Long term investments | ||||
| Property, plant & equipment | $11.9 | $19.73 | $20.97 | $21.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $235.1 | $295.08 | $338.8 | $339.8 |
| Current liabilities | ||||
| Accounts payable | $5.2 | $12.69 | $17.26 | $17.98 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $166.4 | $59.98 | $69.37 | $68.88 |
| Long term debt | $1.8 | $143.27 | $151.47 | $146.24 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $171 | $210.94 | $236.59 | $234.66 |
| Shareholders' equity | ||||
| Retained earnings | -$614 | -$593.42 | -$574.29 | -$566.21 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.48 | $1.58 | ||
| Short term investments | ||||
| Net receivables | $21.86 | $22.8 | $0 | $0 |
| Inventory | $0.16 | $2.93 | $0.12 | |
| Total current assets | $43.32 | $106.75 | $0.54 | $1.74 |
| Long term investments | ||||
| Property, plant & equipment | $21.28 | $56.07 | $0.15 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $168.38 | $174.03 | ||
| Total investments | ||||
| Total assets | $339.8 | $569.31 | $168.93 | $175.77 |
| Current liabilities | ||||
| Accounts payable | $17.98 | $13.6 | $0.1 | $0.16 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $68.88 | $96.7 | $2.56 | $0.34 |
| Long term debt | $146.24 | $98.75 | $0.72 | |
| Total noncurrent liabilities | $161.37 | $170.43 | ||
| Total debt | ||||
| Total liabilities | $234.66 | $250.84 | $163.93 | $170.77 |
| Shareholders' equity | ||||
| Retained earnings | -$566.21 | -$343.21 | -$3.83 | $0.3 |
| Other shareholder equity | -$3.8 | -$0 | ||
| Total shareholder equity | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $43.67 | $49.07 | ||
| Cost of revenue | ||||
| Gross Profit | $21.3 | $19.78 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $24.6 | $22.92 | ||
| Operating income | -$2.85 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$2.23 | $6.7 | ||
| Interest expense | -$4.67 | $8.14 | ||
| Net income | ||||
| Net income | -$12.44 | $32.82 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3.95 | $0.95 | ||
| Operating income | -$3.95 | -$0.95 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.27 | $0.56 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$4.13 | $0.3 | ||
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Net income | -$2.99 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$48.41 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3.78 | -$1.66 | $0.74 | $2.64 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$23.58 | -$1.02 | $135.87 | $112.52 |
| Effect of exchange rate | -$0.46 | -$0.39 | $0.64 | -$0.81 |
| Change in cash and equivalents | -$35.66 | -$6.15 | $74.43 | $65.94 |
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | |
|---|---|---|---|---|
| Net income | -$4.13 | $0.3 | ||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$2.06 | -$1.48 | ||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $0.74 | $6.63 | -$172.12 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $135.87 | -$5.67 | $175.18 | |
| Effect of exchange rate | $0.64 | |||
| Change in cash and equivalents | $74.43 | -$1.1 | $1.58 | |
News
Fundamentals
| Market cap | $6.16M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 17.60M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 36.97% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.13 |
| Quick ratio | N/A |